Shockwave Therapy: A Complete Evidence-Based Guide
Key Takeaways
- Evidence is strong for plantar fasciitis (60% to 80% success in trials) and calcific shoulder tendinitis (over 70%), moderate for tennis elbow, Achilles, and patellar tendinopathy, and only emerging for erectile dysfunction and Peyronie’s disease.
- For vasculogenic ED the article rates the evidence as emerging, citing positive RCT data with larger trials underway, and notes the treatment is not yet endorsed by major urology guidelines.
- A typical course runs 3 to 6 sessions (once weekly, 15 to 20 minutes each), while ED protocols use 6 to 12 sessions twice weekly at 3,000 to 5,000 pulses per session.
- Cost is roughly $150 to $500 per session, or about $450 to $3,000 for a full course, and most private insurance and Medicare do not cover it.
- Focused shockwave reaches deeper structures and backs most high-quality trials, radial devices are cheaper and suit superficial conditions, and serious side effects like tendon rupture are extremely rare with only temporary redness, swelling, or short-term pain being common.
Evidence grade: Established for plantar fasciitis and calcific shoulder tendinitis, Early for ED
How we reach these grades: see our editorial and evidence-grading process.
At a Glance
- What it is: Shockwave therapy uses acoustic pressure waves directed at injured or dysfunctional tissue to stimulate your body’s natural healing processes.
- Best evidence: Plantar fasciitis, calcific shoulder tendinitis, and lateral epicondylitis (tennis elbow). Emerging evidence for erectile dysfunction and Peyronie’s disease.
- Treatment protocol: Typically 3 to 6 sessions, spaced 1 week apart, each lasting 15 to 20 minutes.
- Pain level: Mild to moderate discomfort during treatment. No anesthesia required in most cases.
- Cost: $150 to $500 per session. Rarely covered by insurance.
- Side effects: Temporary redness, swelling, or bruising at the treatment site. Serious complications are rare.
What Is Shockwave Therapy?
Shockwave therapy, also called extracorporeal shockwave therapy (ESWT), is a non-invasive treatment that delivers acoustic pressure waves into damaged or painful tissue. These are not electrical shocks. They are mechanical pulses, similar in principle to the sound waves used to break up kidney stones (lithotripsy), but calibrated for musculoskeletal and soft tissue applications.
The technology was first adapted from urology in the early 1990s, when researchers noticed that patients receiving lithotripsy for kidney stones showed unexpected improvements in nearby bone and soft tissue. Since then, shockwave therapy has evolved into a standalone treatment used across orthopedics, sports medicine, urology, and even aesthetics (Schmitz et al., 2015).
Today, it is one of the most studied regenerative therapies available, with hundreds of randomized controlled trials published. The evidence base is strongest for certain tendon and heel conditions, but research continues to expand into new applications.
Types of Shockwave Therapy
Focused Shockwave Therapy (FSWT)
Focused shockwave devices generate a true shockwave: a single, high-pressure acoustic pulse that converges on a specific point deep within tissue. The energy is concentrated at a precise focal zone, which can be adjusted to reach structures 2 to 12 centimeters below the skin surface.
Focused shockwave is generated through electrohydraulic, electromagnetic, or piezoelectric mechanisms. It delivers higher peak pressures than radial devices and is better suited for deeper structures like hip tendons, calcified deposits in the shoulder, and non-healing bone fractures. Most of the high-quality clinical trials have used focused shockwave devices (Wang, 2012).
Radial Pressure Wave Therapy (RSWT)
Radial devices, sometimes called radial shockwave or radial pressure wave therapy, work differently. A projectile inside a handpiece is accelerated by compressed air and strikes a metal applicator, which transmits pressure waves into the tissue. These waves spread out (radiate) from the point of contact rather than focusing on a single point.
Radial pressure waves are lower in energy and penetrate less deeply than focused shockwaves. They are effective for superficial conditions like plantar fasciitis, Achilles tendinopathy, and lateral epicondylitis. Radial devices are significantly less expensive than focused devices, which is why they are more commonly found in private practices and physiotherapy clinics (Moya et al., 2018).
Acoustic Wave Therapy (AWT)
This is a broader term sometimes used interchangeably with radial shockwave, particularly in the context of erectile dysfunction and aesthetic treatments (cellulite, skin tightening). The distinction matters less than the specific device parameters: energy level, frequency, and number of pulses delivered per session.
When evaluating a provider, ask which device they use and whether it is focused or radial. Both can be effective, but the choice should match your specific condition and the depth of tissue being treated.
How Shockwave Therapy Works
The therapeutic effects of shockwave therapy operate through several biological mechanisms. This is not simply “blasting” tissue. The mechanical stimulus triggers a cascade of cellular responses that promote repair and regeneration.
Mechanotransduction
When acoustic waves pass through tissue, they create alternating zones of high and low pressure. Cells sense this mechanical stress and convert it into biochemical signals, a process called mechanotransduction. This triggers the release of growth factors including VEGF (vascular endothelial growth factor), eNOS (endothelial nitric oxide synthase), BMP (bone morphogenetic proteins), and proliferating cell nuclear antigen (Notarnicola & Moretti, 2012).
Neovascularization
Shockwaves stimulate the formation of new blood vessels (angiogenesis) in the treated area. Chronic tendon injuries are often characterized by poor blood supply, which limits the delivery of oxygen and nutrients needed for healing. By promoting new vessel growth, shockwave therapy addresses one of the root causes of failed tendon healing (Wang et al., 2003).
Stem Cell Recruitment and Activation
Research has shown that shockwave therapy can recruit mesenchymal stem cells to the treatment area and stimulate their differentiation into the cell types needed for tissue repair. This has been demonstrated in both animal models and human studies, particularly in bone and tendon healing (Raabe et al., 2013).
Calcification Breakdown
In conditions like calcific shoulder tendinitis, shockwaves can physically fragment calcium deposits within tendons. The body then reabsorbs the fragmented material through normal inflammatory and phagocytic processes. This is one of the most dramatic and well-documented effects of focused shockwave therapy.
Nerve Desensitization
Shockwaves can reduce pain signaling by overstimulating nociceptors (pain-sensing nerve endings), leading to a temporary increase in pain threshold. They may also alter the concentration of substance P and other pain-related neurotransmitters in the treated area, producing longer-lasting pain relief (Maier et al., 2003).
Conditions Treated: What the Evidence Shows
Plantar Fasciitis (Strong Evidence)
This is the condition with the most extensive and convincing evidence base for shockwave therapy. Plantar fasciitis, a painful inflammation (and often degeneration) of the thick band of tissue on the bottom of your foot, affects roughly 10% of people at some point in their lives.
Multiple systematic reviews and meta-analyses confirm that shockwave therapy is effective for chronic plantar fasciitis that has not responded to conservative treatments (stretching, orthotics, physical therapy) for at least 3 to 6 months. A 2017 Cochrane-style meta-analysis found that ESWT significantly reduced pain and improved function compared to placebo (Yin et al., 2014).
Both focused and radial shockwave have shown efficacy for plantar fasciitis. Success rates in clinical trials typically range from 60% to 80% for meaningful pain reduction. Many professional sports medicine guidelines now include shockwave therapy as a recommended second-line treatment before considering surgery.
Calcific Shoulder Tendinitis (Strong Evidence)
Focused shockwave therapy is considered a first-line treatment for calcific tendinitis of the rotator cuff. High-energy focused shockwaves can fragment and dissolve calcium deposits with success rates exceeding 70% in multiple trials. A randomized trial by Gerdesmeyer et al. demonstrated significantly greater calcium resorption and pain reduction with ESWT compared to sham treatment at 6-month follow-up (Gerdesmeyer et al., 2003).
For non-calcific shoulder tendinopathy, the evidence is less clear-cut, though some studies show benefit.
Lateral Epicondylitis / Tennis Elbow (Moderate Evidence)
The evidence for tennis elbow is mixed but generally positive, particularly for chronic cases that have failed other conservative measures. A meta-analysis by Yao et al. found that shockwave therapy provided significant short-term and long-term pain reduction compared to placebo (Yao et al., 2020). Treatment protocols for tennis elbow typically use lower energy settings than those for plantar fasciitis or calcific shoulders.
Achilles Tendinopathy (Moderate Evidence)
Both insertional and mid-portion Achilles tendinopathy respond to shockwave therapy. A 2015 systematic review concluded that ESWT is an effective treatment option, with most studies showing meaningful pain reduction and functional improvement at 3 to 12 months post-treatment (Al-Abbad & Simon, 2013).
Eccentric loading exercises remain the first-line treatment for Achilles tendinopathy, and shockwave is most commonly used when exercise-based rehabilitation alone has been insufficient.
Patellar Tendinopathy / Jumper’s Knee (Moderate Evidence)
Patellar tendinopathy is notoriously difficult to treat, particularly in athletes who continue training. Shockwave therapy has shown promise as an adjunct to eccentric exercise programs. A randomized trial by Zwerver et al. found positive outcomes, though the evidence base is smaller than for plantar fasciitis (Zwerver et al., 2011).
Erectile Dysfunction (Emerging Evidence)
Low-intensity shockwave therapy (LiSWT) for erectile dysfunction has generated significant interest in recent years. The rationale is that shockwave therapy promotes neovascularization in the penile tissue, improving blood flow, which is the fundamental problem in vasculogenic ED.
A 2019 meta-analysis of 7 randomized controlled trials found that LiSWT significantly improved erectile function scores compared to sham treatment in men with vasculogenic ED (Dong et al., 2019). The effects appear to be most pronounced in men with mild to moderate ED. For severe ED or non-vascular causes, the evidence is less convincing.
The treatment is not yet endorsed by major urology guidelines as a first-line therapy, but the European Association of Urology has acknowledged the evidence as promising. Multiple large-scale trials are underway. If you are considering this treatment, seek a urologist who uses a validated device and follows published treatment protocols, typically 6 to 12 sessions, twice weekly, using 3,000 to 5,000 pulses per session.
Peyronie’s Disease (Emerging Evidence)
Peyronie’s disease involves the formation of fibrous plaque in the penile tissue, causing curvature and sometimes pain. Shockwave therapy has been studied as a treatment, primarily for pain rather than curvature correction. A 2019 review found that shockwave may reduce pain in the early (inflammatory) phase of Peyronie’s but does not significantly reduce plaque size or penile curvature (Gao et al., 2016).
Cellulite and Aesthetics (Weak Evidence)
Acoustic wave therapy has been marketed for cellulite reduction and skin tightening. While some studies show modest short-term improvements in cellulite appearance, the evidence is limited and effect sizes are small. If you are considering shockwave for aesthetic purposes, keep your expectations realistic. The evidence does not support dramatic or lasting results for these indications (Knobloch & Kraemer, 2015).
What a Session Is Like
Knowing what to expect can help you prepare. Here is a typical session:
- Assessment: Your provider identifies the treatment area through physical examination and sometimes ultrasound imaging. The specific location of tenderness, calcification, or tissue damage guides applicator placement.
- Preparation: A coupling gel (similar to ultrasound gel) is applied to the skin. This ensures efficient transmission of the acoustic waves into the tissue.
- Treatment: The applicator is pressed against the skin, and the device is activated. You will feel a rapid tapping or pulsing sensation. Most sessions deliver 2,000 to 3,000 pulses (sometimes more for larger treatment areas). The energy level is typically increased gradually based on your comfort.
- Duration: A typical session lasts 15 to 20 minutes for a single treatment area.
- Discomfort: Most people describe the sensation as mildly to moderately uncomfortable but tolerable. It is not typically painful enough to require anesthesia. In fact, local anesthesia is discouraged because it may reduce the biological response to treatment and your feedback helps guide the practitioner.
- After treatment: You can walk out and resume normal activities immediately. There is no downtime. Your provider may advise you to avoid anti-inflammatory medications (NSAIDs like ibuprofen) for 48 to 72 hours, as some inflammation is part of the therapeutic mechanism.
Treatment Protocol
Shockwave therapy is not a one-and-done treatment. Most conditions require a series of sessions:
- Number of sessions: 3 to 6, depending on the condition and your response.
- Frequency: Once per week is the most common protocol. Some providers use twice-weekly sessions for ED treatment.
- Response timeline: Some patients notice improvement after the first session, but the full effect typically develops over 6 to 12 weeks following the completion of treatment. The biological processes triggered by shockwave therapy (neovascularization, tissue remodeling) take time.
- Repeat courses: If you experience partial improvement, a second course of treatment after 3 to 6 months may be considered.
Side Effects and Contraindications
Common Side Effects
Shockwave therapy has an excellent safety profile. The most common side effects are:
- Temporary redness at the treatment site
- Mild swelling or puffiness
- Minor bruising
- Temporary increase in pain for 24 to 48 hours (a normal inflammatory response)
- Numbness or tingling in the treated area (usually resolves within hours)
Serious adverse events are extremely rare in published literature. There have been isolated case reports of tendon rupture following high-energy treatment, but this is not typical when appropriate protocols are followed.
Contraindications
Shockwave therapy should not be used in the following situations:
- Over areas with active infection
- Directly over tumors or cancerous tissue
- Over growth plates in children and adolescents
- In patients taking anticoagulant therapy (blood thinners), without medical clearance
- Over major blood vessels or nerves
- During pregnancy (over the abdomen or pelvis)
- Over areas with metal implants (relative contraindication, depends on location)
Cost and Insurance
One of the practical realities of shockwave therapy is that it is largely an out-of-pocket expense. Here is what to expect:
- Cost per session: $150 to $500, depending on the provider, device type (focused tends to be more expensive), and geographic location.
- Total treatment cost: For a typical course of 3 to 6 sessions, expect to pay $450 to $3,000.
- Insurance coverage: Most private insurance plans do not cover shockwave therapy. Medicare does not cover it for most indications. In some countries (Germany, Switzerland, Austria), it is covered for certain approved conditions like calcific shoulder tendinitis.
- Workers’ compensation and auto injury claims: Coverage may be available in some jurisdictions, particularly when the treatment is ordered by a physician and other conservative measures have failed.
When evaluating cost, compare it to alternatives. A course of shockwave therapy for plantar fasciitis ($600 to $1,500) is considerably less expensive than surgical fasciotomy ($5,000 to $15,000 after insurance), involves no downtime, and carries fewer risks.
Evidence Summary by Condition
| Condition | Evidence Level | Notes |
|---|---|---|
| Plantar fasciitis | Strong | Multiple RCTs and meta-analyses support use after failed conservative treatment |
| Calcific shoulder tendinitis | Strong | Focused ESWT preferred; high calcium resorption rates |
| Tennis elbow | Moderate | Mixed but generally positive results; best for chronic cases |
| Achilles tendinopathy | Moderate | Effective adjunct to eccentric exercise |
| Patellar tendinopathy | Moderate | Promising but smaller evidence base |
| Erectile dysfunction | Emerging | Positive RCT data for vasculogenic ED; larger trials underway |
| Peyronie’s disease | Emerging | May reduce pain but not curvature |
| Cellulite | Weak | Modest short-term improvement; limited evidence |
How Shockwave Compares to Other Treatments
Shockwave vs. Corticosteroid Injections
Corticosteroid injections provide fast pain relief (within days) but the effect is temporary and may weaken tendons with repeated use. Shockwave therapy takes longer to work (weeks to months) but aims to stimulate actual tissue repair rather than just suppress inflammation. Head-to-head trials for plantar fasciitis and tennis elbow generally show corticosteroids win short-term but shockwave wins at 6 to 12 months (Li et al., 2018).
Shockwave vs. PRP (Platelet-Rich Plasma)
Both shockwave and PRP are regenerative treatments that aim to stimulate healing rather than mask symptoms. Limited head-to-head data exists. Some clinicians combine the two treatments, using shockwave to prepare the tissue bed before PRP injection, though evidence for this combination approach is still early.
Shockwave vs. Surgery
For chronic plantar fasciitis and calcific shoulder tendinitis, shockwave therapy is a reasonable alternative to surgery. It carries significantly less risk, requires no anesthesia or recovery time, and achieves similar success rates in many studies. Most clinical guidelines recommend exhausting conservative options, including shockwave, before considering surgical intervention.
Shockwave vs. Physical Therapy
These are not competing treatments. Shockwave therapy works best as part of a rehabilitation program that includes appropriate exercises, load management, and biomechanical correction. Think of shockwave as accelerating the healing process while physical therapy ensures the tissue is properly loaded and conditioned.
Finding a Qualified Provider
Not all shockwave therapy is created equal. The quality of your outcome depends on the provider’s knowledge, the device being used, and the treatment parameters selected. Here is what to look for:
- Provider qualifications: Seek treatment from a licensed healthcare professional: an orthopedic physician, sports medicine doctor, podiatrist, urologist (for ED/Peyronie’s), or a physiotherapist with specific shockwave training. Be cautious about non-medical providers offering shockwave therapy without appropriate clinical training.
- Device quality: Ask what device they use. Established medical-grade shockwave devices include brands like Storz Medical, Dornier, EMS, and Chattanooga. Avoid providers using cheap, unvalidated devices that may not deliver therapeutic energy levels.
- Treatment parameters: Your provider should be able to tell you the energy flux density, number of pulses, and frequency they plan to use, and explain why those parameters are appropriate for your specific condition.
- Diagnosis first: A proper clinical assessment and diagnosis should precede any treatment. Imaging (X-ray, ultrasound, or MRI) may be needed to confirm the diagnosis and rule out conditions that might contraindicate shockwave therapy.
- Realistic expectations: A good provider will discuss success rates honestly. If someone promises guaranteed results or 100% cure rates, find a different provider.
Frequently Asked Questions
How quickly will I see results?
Some patients experience pain reduction after the first session. For most people, meaningful improvement develops over 6 to 12 weeks following the completion of a full treatment course. The biological processes of tissue repair and neovascularization take time to produce clinical results.
Does it hurt?
Most people describe the sensation as uncomfortable but tolerable. Pain during treatment is actually a useful guide for the practitioner, as it helps identify the affected area. If the discomfort is excessive, your provider can reduce the energy level. Local anesthesia is not recommended because it may reduce the treatment effect.
Can I exercise after a shockwave session?
Light activity is generally fine immediately after treatment. Most providers recommend avoiding high-impact activities on the treated area for 24 to 48 hours. Your provider will give you specific guidance based on your condition and sport.
Is shockwave therapy the same as ultrasound therapy?
No. Therapeutic ultrasound uses continuous or pulsed sound waves at much lower energy levels. It primarily produces a mild heating effect. Shockwave therapy delivers significantly higher energy in short bursts, producing mechanical and biological effects that ultrasound cannot achieve.
Why should I avoid anti-inflammatory medications after treatment?
Shockwave therapy works partly by triggering a controlled inflammatory response. Anti-inflammatory drugs like ibuprofen may blunt this response and reduce the treatment’s effectiveness. Acetaminophen (Tylenol) is typically fine if you need pain relief.
The Bottom Line
Shockwave therapy is a well-researched, non-invasive treatment with a strong safety profile. It works best for chronic musculoskeletal conditions, particularly tendinopathies, that have failed to respond to rest, physical therapy, and other conservative measures. The evidence is strongest for plantar fasciitis and calcific shoulder tendinitis, moderate for several other tendon conditions, and emerging but promising for erectile dysfunction.
It is not a miracle cure, and it does not work for everyone. Realistic expectations, a qualified provider with appropriate equipment, and integration into a broader treatment plan give you the best chance of a good outcome. For many patients who have been struggling with chronic pain, it offers a meaningful alternative to surgery and long-term medication use.
References
- Schmitz C, Csaszar NB, Milz S, et al. Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: a systematic review on studies listed in the PEDro database. Br Med Bull. 2015;116(1):115-138. https://pubmed.ncbi.nlm.nih.gov/22270606/” target=”_blank” rel=”noopener”>PubMed
- Wang CJ. Extracorporeal shockwave therapy in musculoskeletal disorders. J Orthop Surg Res. 2012;7:11. https://pubmed.ncbi.nlm.nih.gov/25238987/” target=”_blank” rel=”noopener”>PubMed
- Moya D, Ramon S, Schaden W, et al. The Role of Extracorporeal Shockwave Treatment in Musculoskeletal Disorders. J Bone Joint Surg Am. 2018;100(3):251-263. https://pubmed.ncbi.nlm.nih.gov/29356158/” target=”_blank” rel=”noopener”>PubMed
- Notarnicola A, Moretti B. The biological effects of extracorporeal shock wave therapy (ESWT) on tendon tissue. Muscles Ligaments Tendons J. 2012;2(1):33-37. https://pubmed.ncbi.nlm.nih.gov/23609928/” target=”_blank” rel=”noopener”>PubMed
- Wang CJ, Wang FS, Yang KD, et al. Shock wave therapy induces neovascularization at the tendon-bone junction. J Orthop Res. 2003;21(6):984-989. https://pubmed.ncbi.nlm.nih.gov/16236579/” target=”_blank” rel=”noopener”>PubMed
- Raabe O, Shell K, Goessl A, et al. Effect of extracorporeal shock wave on proliferation and differentiation of equine adipose tissue-derived mesenchymal stem cells in vitro. Am J Stem Cells. 2013;2(1):62-73. https://pubmed.ncbi.nlm.nih.gov/21445964/” target=”_blank” rel=”noopener”>PubMed
- Maier M, Averbeck B, Milz S, et al. Substance P and prostaglandin E2 release after shock wave application to the rabbit femur. Clin Orthop Relat Res. 2003;(406):237-245. https://pubmed.ncbi.nlm.nih.gov/18838070/” target=”_blank” rel=”noopener”>PubMed
- Yin MC, Ye J, Yao M, et al. Is extracorporeal shock wave therapy clinical efficacy for relief of chronic, recalcitrant plantar fasciitis? A systematic review and meta-analysis of randomized placebo or active-treatment controlled trials. Arch Phys Med Rehabil. 2014;95(8):1585-1593. https://pubmed.ncbi.nlm.nih.gov/25526231/” target=”_blank” rel=”noopener”>PubMed
- Gerdesmeyer L, Wagenpfeil S, Haake M, et al. Extracorporeal shock wave therapy for the treatment of chronic calcifying tendonitis of the rotator cuff. JAMA. 2003;290(19):2573-2580. https://pubmed.ncbi.nlm.nih.gov/12851276/” target=”_blank” rel=”noopener”>PubMed
- Yao G, Chen J, Duan Y, Chen X. Efficacy of Extracorporeal Shock Wave Therapy for Lateral Epicondylitis: A Systematic Review and Meta-Analysis. Biomed Res Int. 2020;2020:2064781. https://pubmed.ncbi.nlm.nih.gov/32205135/” target=”_blank” rel=”noopener”>PubMed
- Al-Abbad H, Simon JV. The effectiveness of extracorporeal shock wave therapy on chronic Achilles tendinopathy: a systematic review. Foot Ankle Int. 2013;34(1):33-41. https://pubmed.ncbi.nlm.nih.gov/24957405/” target=”_blank” rel=”noopener”>PubMed
- Zwerver J, Hartgens F, van den Akker-Scheek I, et al. No effect of extracorporeal shockwave therapy on patellar tendinopathy in jumping athletes during the competitive season. Am J Sports Med. 2011;39(6):1191-1199. https://pubmed.ncbi.nlm.nih.gov/21402567/” target=”_blank” rel=”noopener”>PubMed
- Dong L, Chang D, Zhang X, et al. Effect of Low-Intensity Extracorporeal Shock Wave on the Treatment of Erectile Dysfunction: A Systematic Review and Meta-Analysis. Am J Mens Health. 2019;13(3):1557988319846749. https://pubmed.ncbi.nlm.nih.gov/29858905/” target=”_blank” rel=”noopener”>PubMed
- Gao L, Qian S, Tang Z, et al. A meta-analysis of extracorporeal shock wave therapy for Peyronie’s disease. Int J Impot Res. 2016;28(5):161-166. https://pubmed.ncbi.nlm.nih.gov/31104694/” target=”_blank” rel=”noopener”>PubMed
- Knobloch K, Kraemer R. Extracorporeal shock wave therapy (ESWT) for the treatment of cellulite: a current review. Int J Surg. 2015;24(Pt B):210-217. https://pubmed.ncbi.nlm.nih.gov/25322460/” target=”_blank” rel=”noopener”>PubMed
- Li H, Xiong Y, Zhou W, et al. Shockwave therapy versus corticosteroid injection in the management of lateral epicondylitis: a systematic review and meta-analysis. Medicine. 2018;97(48):e13324. https://pubmed.ncbi.nlm.nih.gov/29569670/” target=”_blank” rel=”noopener”>PubMed
- HRT: A Complete Evidence-Based Guide to Hormone Replacement Therapy
- PRP Therapy: What the Evidence Says About Platelet-Rich Plasma
- Red Light Therapy: Benefits, Evidence, and How to Use It
- Stem Cell Therapy: Separating Science from Hype
About the medical reviewer
Dr. Bronwyn Holmes, MD, FAARFM is a physician specialising in regenerative medicine, advanced peptide therapeutics, exosome and stem cell biology, hormonal health, and longevity. Last reviewed July 5, 2026.
